Oct 14th, 2021
Launch of a New Website on Period Pills
Sep 28th, 2021
Newsletter: Vol. 5, No. 3, September 2021
Sep 23rd, 2021
Gynuity’s TelAbortion Study Will Stop Enrolling at the End of this Month
Sep 9th, 2021
Mexico: Supreme Court Declares Criminal Penalties for Abortion Unconstitutional / México: La Suprema Corte Declara Inconstitucionales Sanciones Penales por Aborto
May 3rd, 2021
Newsletter: Vol. 5, No. 2, May 2021
Apr 13th, 2021
Gynuity’s Research is Primary Source Cited in the U.S. Food and Drug Administration’s Decision to Suspend In-Person Mifepristone Dispensing Requirement
Mar 29th, 2021
Expansion of a Direct-to-Patient Telemedicine Abortion Service in the United States and Experience during the COVID-19 Pandemic
Jan 26th, 2021
Feasibility of Multilevel Pregnancy Tests for Telemedicine Abortion Service Follow-up: A Pilot Study
Jan 22nd, 2021
Newsletter: Vol. 5, No. 1, January 2021
Jan 12th, 2021
The Safety and Feasibility of a Family First Aid Approach for the Management of Postpartum Hemorrhage in Home Births: A Pre‑Post Intervention Study in Rural Pakistan
Dec 4th, 2020
New York Times article: Why Some Women Might Want 'Missed-Period Pills'
Dec 3rd, 2020
In the News. New York Times: Why Some Women Might Want 'Missed-Period Pills'
Nov 24th, 2020
Newsletter: Vol. 4, No. 5, November 2020
Oct 30th, 2020
Exploring Potential Interest in Missed Period Pills in two US States
Aug 31st, 2020
Newsletter: Vol. 4, No. 4, August 2020
Jul 22nd, 2020
A Repeat Dose of Misoprostol 800mcg Following Mifepristone for Outpatient Medical Abortion at 64-70 and 71-77 Days of Gestation: A Retrospective Chart Review
Jun 22nd, 2020
Newsletter: Vol. 4, No. 3, June 2020
Jun 17th, 2020
Multi-Level Pregnancy Test Use for Medical Abortion Follow-up after 63 Days’ Gestation: Evidence from Prenatal hCG Data
May 25th, 2020
Annual Gynuity Mifepristone Meeting
Apr 28th, 2020
New York Times article: Abortion by Telemedicine: A Growing Option as Access to Clinics Wanes
Apr 14th, 2020
No-Test Medication Abortion: A Sample Protocol for Increasing Access During a Pandemic and Beyond
Apr 9th, 2020
COVID-19
Mar 18th, 2020
Newsletter: Vol. 4, No. 2, March 2020
Mar 16th, 2020
A Non-Inferiority Study of Outpatient Mifepristone-Misoprostol Medical Abortion at 64-70 Days and 71-77 Days of Gestation
Sensitivity and Specificity of Placental Proteins for Gestational Age Screening: An Exploratory Study
